Neuropsychiatric Symptoms in Cerebral Amyloid Angiopathy: A Significant but Overlooked Association
Abstract
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
Abbreviations
CAA | Cerebral amyloid angiopathy |
NPS | Neuropsychiatric symptoms |
HADS | Hospital Anxiety and Depression Scale |
GDS | Geriatric Depression Scale |
NPI-Q | Neuropsychiatric Inventory Questionnaire |
CES-D | Center for Epidemiologic Studies Depression Scale |
References
- Jäkel, L.; De Kort, A.M.; Klijn, C.J.M.; Schreuder, F.H.B.M.; Verbeek, M.M. Prevalence of cerebral amyloid angiopathy: A systematic review and meta-analysis. Alzheimers Dement. 2022, 18, 10–28. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Yin, X.S.; Sun, J.; Wang, X.; Wu, W.; Chen, Z.; Zhang, D.; Xu, Y.; Chen, Y.; Qiu, W.; Qian, X.; et al. Prevalence of cerebral amyloid angiopathy and its correlation with Alzheimer’s disease and cognition in an autopsy-confirmed cohort from China. Alzheimers Dement. 2025, 17, e70100. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Charidimou, A.; Boulouis, G.; Frosch, M.P.; Baron, J.-C.; Pasi, M.; Albucher, J.F.; Banerjee, G.; Barbato, C.; Bonneville, F.; Brandner, S.; et al. The Boston Criteria Version 2.0 for Cerebral Amyloid Angiopathy: A Multicentre, Retrospective, MRI–neuropathology Diagnostic Accuracy Study. Lancet Neurol. 2022, 21, 714–725. [Google Scholar] [CrossRef]
- Wheeler, K.V.; Irimia, A.; Braskie, M.N. Using Neuroimaging to Study Cerebral Amyloid Angiopathy and Its Relationship to Alzheimer’s Disease. J. Alzheimer’s Dis. 2024, 97, 1479–1502. [Google Scholar] [CrossRef]
- Koemans, E.A.; Chhatwal, J.P.; van Veluw, S.J.; van Etten, E.S.; van Osch, M.J.; van Walderveen, M.A.; Sohrabi, H.R.; Kozberg, M.G.; Shirzadi, Z.; Terwindt, G.M.; et al. Progression of cerebral amyloid angiopathy: A pathophysiological framework. Lancet Neurol. 2023, 22, 632–642. [Google Scholar] [CrossRef]
- Banerjee, G.; Carare, R.; Cordonnier, C.; Greenberg, S.M.; Schneider, J.A.; Smith, E.E.; Van Buchem, M.; Van Der Grond, J.; Verbeek, M.M.; Werring, D.J. The increasing impact of cerebral amyloid angiopathy: Essential new insights for clinical practice. J. Neurol. Neurosurg. Psychiatry 2017, 88, 982–994. [Google Scholar] [CrossRef] [PubMed]
- Jia, X.; Bo, M.; Zhao, H.; Xu, J.; Pan, L.; Lu, Z. Risk factors for recurrent cerebral amyloid angiopathy-related intracerebral hemorrhage. Front. Neurol. 2023, 14, 1265693. [Google Scholar] [CrossRef] [PubMed]
- Boyle, P.A.; Yu, L.; Nag, S.; Leurgans, S.; Wilson, R.S.; Bennett, D.A.; Schneider, J.A. Cerebral amyloid angiopathy and cognitive outcomes in community-based older persons. Neurology 2015, 85, 1930–1936. [Google Scholar] [CrossRef] [PubMed]
- Kaushik, K.; de Kort, A.M.; van Dort, R.; van der Zwet, R.G.; Siegerink, B.; Voigt, S.; van Zwet, E.W.; van der Plas, M.C.; Koemans, E.A.; Rasing, I.; et al. Neuropsychiatric symptoms with focus on apathy and irritability in sporadic and hereditary cerebral amyloid angiopathy. Alzheimer’s Res. Ther. 2024, 16, 74. [Google Scholar] [CrossRef]
- Smith, E.E.; Crites, S.; Wang, M.; Charlton, A.; Zwiers, A.; Sekhon, R.; Sajobi, T.; Camicioli, R.; McCreary, C.R.; Frayne, R.; et al. Cerebral amyloid angiopathy is associated with emotional dysregulation, impulse dyscontrol, and apathy. J. Am. Heart Assoc. 2021, 10, e022089. [Google Scholar] [CrossRef]
- Dörner, M.; Tyndall, A.; Hainc, N.; von Känel, R.; Neumann, K.; Euler, S.; Schreiber, F.; Arndt, P.; Fuchs, E.; Garz, C.; et al. Neuropsychiatric symptoms and lifelong mental activities in cerebral amyloid angiopathy–a cross-sectional study. Alzheimer’s Res. Ther. 2024, 16, 196. [Google Scholar] [CrossRef] [PubMed]
- Kaushik, K.; Waslam, N.G.; van der Zwet, R.G.J.; Voigt, S.; van Dort, R.; van Zwet, E.W.; Terwindt, G.M.; van Etten, E.S.; Wermer, M.J.H. Quality of life, depression and anxiety in cerebral amyloid angiopathy: A cross-sectional study. Eur. J. Neurol. 2024, 31, e16476. [Google Scholar] [CrossRef]
- Chokesuwattanaskul, A.; Zanon Zotin, M.C.; Schoemaker, D.; Sveikata, L.; Gurol, M.E.; Greenberg, S.M.; Viswanathan, A. Apathy in Patients with Cerebral Amyloid Angiopathy: A Multimodal Neuroimaging Study. Neurology 2023, 100, E2007–E2016. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Kang, S.H.; Lee, E.H.; Kim, Y.J.; Jang, H.; Shin, D.; Zetterberg, H.; Blennow, K.; Gonzalez-Ortiz, F.; Ashton, N.J.; Yun, J.; et al. Cerebral Amyloid Angiopathy and Downstream Alzheimer Disease Plasma Biomarkers. JAMA Netw. Open 2025, 8, e258842. [Google Scholar] [CrossRef]
- Devanand, D.P.; Lee, S.; Huey, E.D.; Goldberg, T.E. Associations between neuropsychiatric symptoms and neuropathological diagnoses of Alzheimer disease and related dementias. JAMA Psychiatry 2022, 79, 359–367. [Google Scholar] [CrossRef]
- Schiavolin, S.; Camarda, G.; Mazzucchelli, A.; Mariniello, A.; Marinoni, G.; Storti, B.; Canavero, I.; Bersano, A.; Leonardi, M. Cognitive and psychological characteristics in patients with cerebral amyloid angiopathy: A literature review. Neurol. Sci. 2024, 45, 3031–3049. [Google Scholar] [CrossRef] [PubMed]
- Pink, A.; Krell-Roesch, J.; Syrjanen, J.A.; Vassilaki, M.; Lowe, V.J.; Vemuri, P.; Stokin, G.B.; Christianson, T.J.; Kremers, W.K.; Jack, C.R.; et al. A longitudinal investigation of Aβ, anxiety, depression, and mild cognitive impairment. Alzheimer’s Dement. 2021, 18, 1824–1831. [Google Scholar] [CrossRef]
- Castello, J.P.; Pasi, M.; Kubiszewski, P.; Abramson, J.R.; Charidimou, A.; Kourkoulis, C.; DiPucchio, Z.; Schwab, K.; Anderson, C.D.; Gurol, M.E.; et al. Cerebral Small Vessel Disease and Depression Among Intracerebral Hemorrhage Survivors. Stroke 2021, 53, 523–531. [Google Scholar] [CrossRef] [PubMed] [PubMed Central]
- Planton, M.; Raposo, N.; Albucher, J.F.; Pariente, J. Cerebral amyloid angiopathy-related cognitive impairment: The search for a specific neuropsychological pattern. Rev. Neurol. 2017, 173, 562–565. [Google Scholar] [CrossRef]
- Kubiszewski, P.; Sugita, L.; Kourkoulis, C.; DiPucchio, Z.; Schwab, K.; Anderson, C.D.; Gurol, M.E.; Greenberg, S.M.; Viswanathan, A.; Rosand, J.; et al. Association of Selective Serotonin Reuptake Inhibitor Use After Intracerebral Hemorrhage with Hemorrhage Recurrence and Depression Severity. JAMA Neurol. 2020, 78, 61–67. [Google Scholar] [CrossRef]
- Cummings, J.L. Maximizing the benefit and managing the risk of anti-amyloid monoclonal antibody therapy for Alzheimer’s disease: Strategies and research directions. Neurotherapeutics 2025, 22, e00570. [Google Scholar] [CrossRef] [PubMed]
- Ramanan, V.K.; Armstrong, M.J.; Choudhury, P.; Coerver, K.A.; Hamilton, R.H.; Klein, B.C.; Wolk, D.A.; Wessels, S.R.; Jones, L.K., Jr. AAN Quality Committee. Antiamyloid Monoclonal Antibody Therapy for Alzheimer Disease: Emerging Issues in Neurology. Neurology 2023, 101, 842–852. [Google Scholar] [CrossRef] [PubMed]
- Pozuelo Moyano, B.; Salvioni, P.; Zullo, L.; Rouaud, O.; von Gunten, A.; Girardin, F.R.; Allali, G. Antidepressants and the risk of bleeding in the era of anti-amyloid drugs. Alzheimer’s Dement. 2023, 19, 5847–5848. [Google Scholar] [CrossRef]
- van den Berg, E.; Kersten, I.; Brinkmalm, G.; Johansson, K.; de Kort, A.M.; Klijn, C.J.M.; Schreuder, F.H.B.M.; Gobom, J.; Stoops, E.; Portelius, E.; et al. Profiling amyloid-β peptides as biomarkers for cerebral amyloid angiopathy. J. Neurochem. 2024, 168, 1254–1264. [Google Scholar] [CrossRef] [PubMed]
- Schurgers, G.; Arts, B.M.G.; Postma, A.A.; de Kort, A. Successful electroconvulsive therapy for depression in a man with cerebral amyloid angiopathy. BMJ Case Rep. 2021, 14, e238922. [Google Scholar] [CrossRef]
- Gray, Z.A.; Greenberg, S.M.; Press, D.Z. rTMS for treatment of depression in a patient with cerebral amyloid angiopathy: A case report on safety and efficacy. Brain Stimul. 2014, 7, 495–497. [Google Scholar] [CrossRef]
- van Dort, R.; Kaushik, K.; Rasing, I.; van der Zwet, R.G.; Schipper, M.R.; van der Grond, J.; van Rooden, S.; van Zwet, E.W.; Terwindt, G.M.; Middelkoop, H.A.; et al. Cognition in (pre) symptomatic Dutch-type hereditary and sporadic cerebral amyloid angiopathy. Alzheimer’s Dement. 2024, 20, 7518–7528. [Google Scholar] [CrossRef]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Rus Prelog, P.; Zupan, M.; Frol, S. Neuropsychiatric Symptoms in Cerebral Amyloid Angiopathy: A Significant but Overlooked Association. Brain Sci. 2025, 15, 959. https://doi.org/10.3390/brainsci15090959
Rus Prelog P, Zupan M, Frol S. Neuropsychiatric Symptoms in Cerebral Amyloid Angiopathy: A Significant but Overlooked Association. Brain Sciences. 2025; 15(9):959. https://doi.org/10.3390/brainsci15090959
Chicago/Turabian StyleRus Prelog, Polona, Matija Zupan, and Senta Frol. 2025. "Neuropsychiatric Symptoms in Cerebral Amyloid Angiopathy: A Significant but Overlooked Association" Brain Sciences 15, no. 9: 959. https://doi.org/10.3390/brainsci15090959
APA StyleRus Prelog, P., Zupan, M., & Frol, S. (2025). Neuropsychiatric Symptoms in Cerebral Amyloid Angiopathy: A Significant but Overlooked Association. Brain Sciences, 15(9), 959. https://doi.org/10.3390/brainsci15090959